- Home
- FUFUW vs JSPRW Comparison
FUFUW vs JSPRW Comparison
Compare FUFUW & JSPRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUFUW
- JSPRW
- Stock Information
- Founded
- FUFUW N/A
- JSPRW N/A
- Country
- FUFUW Singapore
- JSPRW United States
- Employees
- FUFUW N/A
- JSPRW N/A
- Industry
- FUFUW
- JSPRW Biotechnology: Pharmaceutical Preparations
- Sector
- FUFUW
- JSPRW Health Care
- Exchange
- FUFUW Nasdaq
- JSPRW Nasdaq
- Market Cap
- FUFUW N/A
- JSPRW N/A
- IPO Year
- FUFUW N/A
- JSPRW N/A
- Fundamental
- Price
- FUFUW $0.43
- JSPRW $0.14
- Analyst Decision
- FUFUW
- JSPRW
- Analyst Count
- FUFUW 0
- JSPRW 0
- Target Price
- FUFUW N/A
- JSPRW N/A
- AVG Volume (30 Days)
- FUFUW 5.6K
- JSPRW 7.8K
- Earning Date
- FUFUW 04-11-2025
- JSPRW 03-05-2025
- Dividend Yield
- FUFUW N/A
- JSPRW N/A
- EPS Growth
- FUFUW 1042.93
- JSPRW N/A
- EPS
- FUFUW 0.23
- JSPRW N/A
- Revenue
- FUFUW $452,743,012.00
- JSPRW N/A
- Revenue This Year
- FUFUW N/A
- JSPRW N/A
- Revenue Next Year
- FUFUW N/A
- JSPRW N/A
- P/E Ratio
- FUFUW $22.02
- JSPRW N/A
- Revenue Growth
- FUFUW 78.43
- JSPRW N/A
- 52 Week Low
- FUFUW $0.46
- JSPRW $0.15
- 52 Week High
- FUFUW $0.54
- JSPRW $0.16
- Technical
- Relative Strength Index (RSI)
- FUFUW N/A
- JSPRW N/A
- Support Level
- FUFUW N/A
- JSPRW N/A
- Resistance Level
- FUFUW N/A
- JSPRW N/A
- Average True Range (ATR)
- FUFUW 0.00
- JSPRW 0.00
- MACD
- FUFUW 0.00
- JSPRW 0.00
- Stochastic Oscillator
- FUFUW 0.00
- JSPRW 0.00
About FUFUW BitFuFu Inc.
BitFuFu Inc is a digital asset mining and cloud-mining service provider that fosters a secure, compliant, and transparent blockchain infrastructure. It provides stable and intelligent digital asset mining solutions, including one-stop cloud-mining services and miner hosting services to institutional customers and individual digital assets.
About JSPRW Japer Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.